To include your compound in the COVID-19 Resource Center, submit it here.

Genzyme beats Street EPS

GENZ reported third quarter EPS of $0.37, which was $0.03 better than the Street's $0.34 consensus estimate and

Read the full 187 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE